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S52Objectives: There is increasing attention to prophylactic replacement of the moderately dilated ascending aorta
at aortic valve surgery. Moderate ascending aortic dilatation is common in adult patients with conotruncal anom-
alies. There are no data outlining actual risk of progressive ascending aortic dilatation or dissection to provide
management guidelines.
Methods: From December 1973 through January 2008, 81 consecutive adults (median age, 34 years; range, 18–
59 years) with conotruncal anomalies underwent operation on the aortic root, ascending aorta, or aortic valve.
Primary cardiac diagnoses included tetralogy of Fallot with or without pulmonary atresia in 60 patients, truncus
arteriosus in 12, double-outlet right ventricle in 6, and other in 3. Indications for operation included aortic re-
gurgitation in 69 patients, supracoronary ascending aneurysm in 16, aortic stenosis in 5, and other in 8. Median
ascending aortic size was 45 mm (23–80 mm).
Results: Operations included isolated aortic valve repair/replacement in 63 patients, combined aortic valve re-
placement and reduction aortoplasty in 9, aortic root replacement in 7, and isolated ascending aortic replacement
in 2. Four patients required reoperation during a median follow-up of 3.8 years (maximum 31 years). There were
no ascending aortic reoperations after previous reduction aortoplasties or supracoronary ascending aortic grafts,
and there were no late aortic dissections.
Conclusions: Moderate ascending aortic enlargement is common among patients with conotruncal anomalies
coming to operation, but aortic dissection is rare, as is subsequent need for aortic reoperation. Despite current
enthusiasm for prophylactic operations on the ascending aorta in patients with acquired disease, these data
suggest that the moderately dilated aorta in this setting may be observed. (J Thorac Cardiovasc Surg
2010;140:S52-7)Conotruncal anomalies such as tetralogy of Fallot with or
without pulmonary atresia, double-outlet right ventricle,
truncus arteriosus, and transposition of the great arteries
are congenital heart defects characterized by abnormalities
of the outflow tracts and great vessels. Complete repair of
each of these defects is generally performed during infancy
with low early mortality, and late survival is excellent.
Many long-term survivors, however, will eventually require
reoperation at least once.1
Most of the medical literature concerning conotruncal ab-
normalities focuses on the reoperativemanagement of regur-
gitant or obstructive lesions of the right-sided outflow tract. It
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The Journal of Thoracic and Cardiovascular Surgin a conotruncal anomaly to be dilated at birth and at initial
repair.1-3 The pathophysiology of aortic root dilatation in
conotruncal abnormalities is likely a combination of
increased aortic blood flow before complete repair and
intrinsic vascular structural abnormalities.2-5 Further, this
progression of aortic root dilatation despite complete
repair suggests the possibility of an intrinsic aortopathy,
such as seen in Marfan syndrome; aortic specimens from
patients with conotruncal defects had significant medial
wall abnormalities of the smooth muscle, elastic fibers,
collagen, and ground substance.2 Unfortunately, little infor-
mation is available on the management of this increasingly
encountered problem.
The objectives of this review are (1) to outline the risk of
progressive ascending aortic dilatation and dissection in
adult patients with repaired conotruncal anomalies under-
going surgery on the aortic root, aortic valve, or ascending
aorta and (2) to provide reasonable management strategies
and technical issues to help guide the surgeon who is con-
fronted with this growing adult patient population with con-
genital heart disease.6MATERIALS AND METHODS
The Mayo Foundation institutional review board approved this study,
and all patients or their families gave written, informed consent. Betweenery c December 2010
TABLE 1. Previous cardiac procedures performed
Procedure No. of patients
Primary repair of conotruncal anomaly 50
Palliative shunt 23
Right ventricle–pulmonary artery conduit 12
Ventricular septal defect repair 5
Aortic valve replacement 4
Pulmonary arterial banding 3
Unifocalization 3
Pulmonary valve replacement 3
Tricuspid valve replacement 2
Tricuspid valve annuloplasty 2
Pulmonary valvotomy 1
Aortic valve cusp perforation repair 1
Ascending aortic aneurysm repair 1
Reduction ascending aortoplasty 1
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the aortic root, ascending aorta, or aortic valve in patients with a preexisting
diagnosis of conotruncal anomaly. Primary cardiac diagnoses included pul-
monary atresia with ventricular septal defect in 41 patients (51%), tetral-
ogy of Fallot in 19 (23%), truncus arteriosus in 12 (15%), double-outlet
right ventricle in 6 (7%), and transposition of the great arteries in
3 (4%). Median ascending aortic diameters in this study cohort were
45 mm (range, 23–80 mm) for all patients, less than 4 cm in 9 patients, 4
to 5 cm in 66, and greater than 5 cm in 6. For patients undergoing isolated
aortic valve replacement, median aortic annular size was 29 mm (range,
21–43 mm), and median size of the ascending aorta was 45 mm (range,
23–50 mm). There were 44 male patients (54%), and the median age at
operation was 34 years (range, 18–59 years). Hypertension and tobacco
use were uncommon, being present in 11 of 81 (13%) each.
Sixty-five patients (80%) had undergone previous cardiac operations
(corrective or palliative): 33 had undergone 1 previous operation, 19
had undergone 2, 9 had undergone 3, 3 had undergone 4, and 1 had un-
dergone 5. Previous procedures performed are shown in Table 1 and most
commonly included primary repair of the patient’s underlying conotrun-
cal anomaly in 50 patients (62%), palliative shunt in 23 (28%), and right
ventricle–pulmonary artery conduit in 12 (15%). Furthermore, 6 patients
had undergone operations on the aortic valve or ascending aorta before
presentation at our institution; these included isolated aortic valve re-
placement in 3 cases, combined aortic valve replacement and reduction
ascending aortoplasty in 1, repair of ascending aortic false aneurysm in
1, isolated ascending aortoplasty in 1, and aortic valve cusp perforation
repair in 1.
Indications and timing for operation were guided by right-sided abnor-
malities and residual intracardiac defects for most patients. At the time of
operation, abnormalities on the aortic valve or ascending aorta included
aortic valve regurgitation in 69 cases (85%), ascending aortic aneurysm
in 16 (20%), aortic valve stenosis in 5 (6%), mixed aortic valve stenosis
and regurgitation in 4 (5%), aortic root aneurysm in 3 (4%), and acute
ascending aortic dissection in 1 (1%). Interestingly, there were 671 op-
erations performed for acute ascending aortic dissection during the study
interval (1973 and 2008), and only 1 patient had a congenital diagnosis;
that patient was a 26-year-old with palliated pulmonary atresia with ven-
tricular septal defect who had previously undergone a central shunt. The
site of dissection originated at the anastomotic line in the ascending
aorta.
Statistical Analysis
Demographic and other patient-related data were obtained from Mayo
Clinic medical records. Follow-up information was obtained from subse-
quent clinic visits, written correspondence from local physicians, and
mailed questionnaires to patients or families. Data are expressed as the me-
dian value with a range. Survival and freedom from reoperation were deter-
mined with Kaplan–Meier analysis. Early operative mortality was defined
as death occurring within 30 days of operation or at any time during the in-
dex hospitalization.RESULTS
All patients underwent operations on the aortic root, aor-
tic valve, or ascending aorta at our institution. Procedures
performed included isolated aortic valve replacement in
53 cases (65%), aortic valve repair in 10 (12%), combined
aortic valve replacement and reduction ascending aorto-
plasty in 9 (11%), aortic root replacement in 7 (9%), and
isolated ascending aortic aneurysm repair in 2 (2%).
For isolated aortic valve replacement, a mechanical pros-
thesis was used in 44 patients (71%) and a heterograft bio-The Journal of Thoracic and Carprosthesis in 18 (29%). Techniques used for aortic valve
repair (n ¼ 10) included commissural plication in 7 pa-
tients, perforation repair in 2, and decalcification in 1.
The median size of the aortic valve prostheses used was
27 mm (range, 21–39 mm). A mechanical aortic composite
graft was used in all 7 patients undergoing aortic root re-
placement (median size, 31; range, 25–34 mm). Reduction
ascending aortoplasty was performed in 9 patients with
a median ascending aortic diameter of 50 mm (range, 48–
59 mm), and a supracoronary tube graft was used in 2 pa-
tients with ascending aortic aneurysm (sizes 57 and
59 mm) with graft sizes of 25 and 31 mm.
Concomitant procedures performed, shown in Table 2,
most commonly included pulmonary valve replacement in
24 patients (30%), primary repair of underlying conotrun-
cal anomaly in 16 (20%), and replacement of preexisting
right ventricle–pulmonary artery conduit in 13 (16%).
There were no perioperative strokes in any patient, and re-
operation for bleeding was required in 5 of 81 cases (6.2%).
Overall early mortality was 6 of 81 (7.4%), with 1 death oc-
curring in the 1970s, 3 in the 1980s, and 2 in the early 1990s.
There have been no early deaths in the 56 consecutive pa-
tients since 1991. Causes of early death included intractable
ventricular arrhythmias in 3 cases, seizure leading to car-
diac arrest in 1, and acute pulmonary hemorrhage in 1.
The cause of early death could not be ascertained in the
case of 1 patient who died in the 1970s.
Pathologic analysis of ascending aortic specimens was
available for 6 of 7 patients who underwent aortic root re-
placement and for 1 of 2 patients who underwent ascending
aortic graft replacement. Pathologic examination demon-
strated abnormal findings in all but 1 case. Abnormalities
included medial degeneration in 3 patients, medial or ad-
ventitial fibrosis in 2, fibrointimal proliferation in 1, and
fibrocalcific atherosclerosis in 1.
Median follow-up was 3.8 years (maximum 31 years),
and follow-up was available for all 75 early survivors.diovascular Surgery c Volume 140, Number 6S S53
TABLE 2. Concomitant procedures performed
Procedure No. of patients
Pulmonary valve replacement 24
Bioprosthesis 21
Mechanical 3
Primary repair of conotruncal anomaly 16
Right ventricle–pulmonary artery conduit 13
Tricuspid valve annuloplasty 9
Pulmonary artery patch augmentation 8
Ventricular septal defect repair 6
Atrial septal defect repair 5
Mitral valve replacement (all mechanical prostheses) 3
Mitral valve repair 2
FIGURE 1. Overall survival after operation on aortic root, aortic valve, or
ascending aorta.
FIGURE 2. Freedom from subsequent reoperation (reop) on aortic root,
aortic valve, or ascending aorta.
Aortic Symposium 2010 Stulak et alActuarial overall survivals were 84% at 1 year, 69% at 5
years, 60% at 10 years, and 52% at 15 years (Figure 1).
There were 22 late deaths; of these, 15 were cardiac related
and secondary to heart failure or sudden cardiac death or ar-
rhythmia. Cause of late death could not be determined for 7
patients; however, only 1 of these patients had a dilated as-
cending aorta larger than 4.5 cm at the time of operation.
Freedoms from reoperation on the aortic root, aortic
valve, or ascending aorta were 98% at 1 year, 97% at 5
years, and 92% at 10 years (Figure 2). Importantly, for pa-
tients undergoing isolated aortic valve replacement, free-
dom from reoperation on the ascending aorta was 100%
at 10 years, whereas freedoms from reoperation on the aor-
tic valve were 97% at 5 years and 91% at 10 years. There
were no ascending aortic reoperations in patients with pre-
vious reduction ascending aortoplasty or supracoronary as-
cending aorta replacement. Importantly, there were no late
aortic dissections. There were 4 late reoperations: 3 after
aortic valve replacement and 1 after aortic valve repair. In-
dications for subsequent reoperation included paravalvular
leak, bioprosthetic degeneration, severe aortic regurgitation
after aortic repair, and aortic root replacement.
DISCUSSION
In this series, patients with conotruncal anomalies under-
going operation on the aortic root, aortic valve, or ascending
aorta had low early mortality in the current era. Although
reoperations for recurrent right-sided pathology (pulmo-
nary valve, conduit obstruction, or regurgitation) persist
throughout a lifetime, there was a low reoperation rate for
recurrent aortic valve or ascending aortic abnormalities.
All reoperations in these patients were required for recur-
rent aortic valve dysfunction; there were no reoperations
on the ascending aorta. These data suggest that the risk of
ascending aortic dissection or progressive aortic dilatation
requiring intervention is very low, despite the presence of
a moderately dilated ascending aorta in the many of these
patients. Specifically, there was no need for subsequent re-
operations in patients who underwent ascending reduction
aortoplasty or supracoronary ascending aortic replacement.S54 The Journal of Thoracic and Cardiovascular SurgDespite enthusiasm for prophylactic operations on the
ascending aorta in patients with acquired heart disease or bi-
cuspid aortic valve disease, the moderately dilated aorta in
this setting may be managed by observation alone.
There are few data in the literature about indications for
surgical intervention on the ascending aorta or aortic root in
patients with conotruncal anomalies. Recently, case reports
of aortic aneurysm and ascending aortic dissection in tetral-
ogy of Fallot patients have been reported,7-9 although they
appear to be rare in light of the large number of adult
patients with conotruncal anomalies with dilated ascending
aortas who have survived into adulthood. Potential
important explanations for this rare occurrence of aortic
dissection include the low incidences of hypertension and
smoking among adult patients with congenital heart
disease. This was also the case for the patients in this series.
The natural history and risks of ascending aortic aneurysms
in patients without congenital heart disease have been well
described.10 Current consensus recommendations for adultery c December 2010
Stulak et al Aortic Symposium 2010patientswith congenital heart disease are to repair the ascend-
ing aorta when it is 55 mm or larger,11 whereas others have
suggested earlier intervention when there is moderate or
greater aortic regurgitation.4
The presence of ascending aortic dilatation or aneurysm
in the patient with a conotruncal abnormality is usually not
the main indication for operation. Almost all affected pa-
tients will have undergone at least one previous operation,
usually complete repair. The timing of any reoperations
more often revolves around pathology of the right ventricu-
lar outflow tract and pulmonary valve. Pulmonary regurgi-
tation is the most common lesion, but right ventricular
outflow tract or pulmonary valve obstruction may also be
an indication for reoperation. Concomitant abnormalities,
such as residual ventricular septal defect, atrial septal de-
fect, tricuspid regurgitation, and atrial tachyarrhythmias,
may also be present and are taken into consideration
when determining the best time for reoperation.
Class 1 indications for aortic valve replacement in the set-
ting of aortic regurgitation are as follows: (1) patients with
symptoms and severe aortic regurgitation, irrespective of
left ventricular systolic function; (2) patients without symp-
toms but with chronic severe aortic regurgitation and left
ventricular systolic dysfunction (left ventricular ejection
fraction50%); and (3) patients with chronic severe aortic
regurgitation undergoing coronary artery bypass grafting or
surgery on the aorta or other heart valves.12 Operative inter-
vention for a patient without congenital heart disease and
without a connective tissue disorder is generally recommen-
ded when the ascending aorta ranges from 5 to 5.5 cm.13 For
patients with ascending aortic diameter less than 5 cm who
are being monitored with serial computed tomographic or
magnetic resonance imaging, surgical intervention is indi-
cated when there has been a 10% increase in size during
a 6- to12-month period. Other indications for surgery when
the ascending aorta is smaller than 5.0 cm include rapid
growth of the ascending aorta (>1 cm in a year), a family
history of aortic dissection, and the presence of moderate
or worse aortic regurgitation.14 Operative repair varies ac-
cording to the underlying pathology, the status of the aortic
valve, the general well-being of the patient, the nature of con-
comitant cardiac procedures, and the expected survival of the
patient.
Most patients with repaired conotruncal anomalies come
to medical attention because of right-sided abnormalities
(eg, pulmonary regurgitation). The aorta is incidentally
found to be dilated during the course of evaluation for other
cardiac disorders. The presence of ascending aortic dilata-
tion alone typically does not cause symptoms. If the ascend-
ing aortic dilatation is associated with significant aortic
annular dilatation, then symptoms of aortic regurgitation
may also be present. Chest or back pain may indicate acute
expansion or dissection, both of which have been rarely re-
ported in the setting of conotruncal abnormalities.7-9The Journal of Thoracic and CarComputed tomographic or magnetic resonance imaging
before operation is important in this group of patients
when planning a reoperative median sternotomy. The
dilated ascending aorta may be particularly susceptible to
injury with tetralogy of Fallot, pulmonary atresia, or double
outlet-right ventricle with sternal reentry because of its
midline position and anterior displacement. In contrast,
a right ventricle–pulmonary artery conduit is vulnerable
to injury in patients with truncus arteriosus and transposi-
tion of the great arteries who have previously undergone
a Rastelli procedure because of its more midline position.
In addition, the anteriorly positioned pulmonary confluence
(which may also be dilated) in patients who have previ-
ously undergone the arterial switch procedure with the Le-
compte maneuver may be at risk during sternal reentry.
Any stenoses or dilatation of the main or branch pulmonary
arteries and their position relative to the sternum are readily
determined by computed tomographic or magnetic reso-
nance imaging. Finally, the precise coronary artery anom-
alies (eg, left anterior descending from the right coronary
artery) can also be ascertained by computed tomographic
or magnetic resonance imaging studies and are essential
to know preoperatively, because it can be difficult to find
the coronary arteries and determine their courses at the
time of reoperation. Coronary angiography can also be per-
formed to determine coronary artery anatomy and detect
the presence of obstructive coronary artery disease second-
ary to atherosclerosis.
Thevastmajority ofpatientswhoundergooperation require
replacement of the pulmonary valve in addition to a procedure
on the aorta or aortic valve. If the native aortic valve can be
preserved, then we use a tissue valve for pulmonary valve re-
placement because of the relative good durability and the lack
of a need for long-term anticoagulation.15-17 If the aortic valve
requires replacement, then the selection of mechanical or
tissue prosthesis for aortic valve replacement is made on an
individual basis. If aortic root replacement with a composite
graft is required, then we use a mechanical valved conduit in
most instances. In addition, because it is common for there
to have been 2 or more previous sternotomies, stronger
consideration is given to a mechanical prosthesis when
aortic valve replacement is required. If mechanical aortic
valve replacement is planned, then we generally perform
mechanical pulmonary valve replacement as well, because
anticoagulation will be required anyway. Details of our
mechanical pulmonary valve replacement techniques have
been reported elsewhere.18
If aortic root replacement is required and a tissue valve is
preferred, then the options for aortic valve replacement in-
clude a stentless porcine bioprosthesis, a stented porcine or
pericardial bioprosthesis that is hand sewn to an appropri-
ately sized Dacron polyester fabric tube graft, or an aortic
homograft. We generally reserve the aortic homograft
root replacement for cases of active endocarditis with aorticdiovascular Surgery c Volume 140, Number 6S S55
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generous coronary buttons to facilitate subsequent reopera-
tions when the coronary buttons will need to mobilized and
reimplanted. In addition, because the homograft eventually
becomes circumferentially calcified, we prefer to make it as
short as possible; that is, we transect it just above the homo-
graft valve commissures and use a Dacron polyester fabric
tube graft to bridge the distance to the distal ascending
aorta or aortic arch anastomosis. This also simplifies and
facilitates subsequent reoperation by allowing distal aortic
or arch cannulation and crossclamp and aortic tack vent
placement.
It is important to note that the vast majority of patients in
this series underwent repair of their underlying anomalies
beyond infancy. The literature has suggested that progres-
sion of aortic pathology in the conotruncal anomaly may
be reduced when complete repair is performed in the first
year of life, which is the surgical approach in the current
era.19 Analysis of ascending aortic tissue resected from
these patients and in other series yielded abnormal findings
in most cases. Indeed, the progression of aortic root dilata-
tion observed in these patients suggests the possibility of an
intrinsic aortopathy, such as is seen in Marfan syndrome.
Niwa and colleagues2 examined aortic specimens from 18
patients with congenital heart defects by means of light
and electron microscopy. The conotruncal defects evaluated
included tetralogy of Fallot with or without pulmonary atre-
sia, transposition of the great arteries, truncus arteriosus,
and double-outlet right ventricle. All the aortic specimens
of the conotruncal defects had medial wall abnormalities
of the smooth muscle, elastic fibers, collagen, and ground
substance. Niwa and colleagues2 acknowledged that this
could lead to aortic dilatation, aneurysm formation, and
possible aortic rupture. The question of whether progressive
enlargement of the ascending aorta is due to an inherent or
an acquired aortopathy in this group of patients remains un-
answered.
It is difficult to make rigid recommendations about the
timing of intervention and the optimal procedure to be per-
formed on the aortic root in the setting of a conotruncal
anomaly, because there are few data available in the litera-
ture. To our knowledge, there have been only 2 case reports
of ascending aortic dissection and rupture in the literature.
Although we had 1 dissection in our patient cohort, it was
related to a suture line of a previous shunt originating
from the ascending aorta. Overall, ascending aortic dissec-
tion appears to be rare in the setting of a conotruncal anom-
aly and may be related to uniform dilatation of the
ascending aorta, aortic arch, and descending aorta, or to
the absence of hypertension and smoking in many of these
patients.
The timing of operation when aortic regurgitation is pres-
ent should be no different than for aortic regurgitation in the
setting of a bicuspid aortic valve or acquired valvular heartS56 The Journal of Thoracic and Cardiovascular Surgdisease; recommendations for intervention are outlined in
the American College of Cardiology and American Heart
Association valve guidelines.12 The timing of operation
with regard to the size of the aortic root is more difficult.
In the absence of a family history of aortic dissection or
aneurysm or documented rapid growth of the ascending
aorta, we would proceed with replacement of the ascending
aorta when the size is at least 55 mm. When the size of the
ascending aorta is 50 to 55 mm, we have individually tai-
lored the treatment according to associated anomalies that
need to be addressed, patient comorbidities, and life expec-
tancy. For this group of patients, we consider a simple re-
duction ascending aortoplasty. We generally proceed with
root replacement and coronary reimplantation when there
is effacement of the sinotubular junction, or when there is
severe dilatation of the aortic root with an intact sinotubular
junction. Specifically, if the ascending aorta is at least
55 mm with an intact sinotubular junction and the sinuses
are not more than 40 mm, then we use a supracoronary
tube graft. Associated cardiac abnormalities are addressed
as needed.
In our experience, moderate ascending aortic enlarge-
ment is common among patients with conotruncal anoma-
lies coming to aortic valve surgery. Because aortic
dissection and the subsequent need for reoperation appear
to be infrequent in this setting, we believe that the moder-
ately dilated aorta may be managed with observation.References
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